Subscribe
shutterstock_621316742_tero_vesalainen
Tero Vesalainen / Shutterstock.com
24 March 2022GenericsAlex Baldwin

Campaigners ask US govt to force down prices for common drugs

Entities backing the Make Meds Affordable campaign have asked US health authorities President Biden to end “patent monopolies” on six common medicines to bring down prices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Clarivate’s ‘drugs to watch’ list signals high prices to come
11 February 2020   Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.
Americas
Mexican Senate launches bill to modify patented drug prices
21 February 2019   The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
Clarivate’s ‘drugs to watch’ list signals high prices to come
11 February 2020   Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.
Americas
Mexican Senate launches bill to modify patented drug prices
21 February 2019   The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.

More on this story

Big Pharma
Clarivate’s ‘drugs to watch’ list signals high prices to come
11 February 2020   Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.
Americas
Mexican Senate launches bill to modify patented drug prices
21 February 2019   The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility